Jeeva Informatics Archives · BioBuzz

Loading …

Jeeva Informatics Hosts Rare Disease Panel on Decentralized, Patient-Focused Clinical Trials

<img width="300" height="300" alt="" data-srcset="https://biobuzz.io/wp-content/uploads/2021/02/Jeeva-Informatics-Hosts-Rare-Disease-Panel-on-Decentralized-Patient-Focused-Clinical-Trials-300x300.jpeg 300w, https://biobuzz.io/wp-content/uploads/2021/02/Jeeva-Informatics-Hosts-Rare-Disease-Panel-on-Decentralized-Patient-Focused-Clinical-Trials-150x150.jpeg 150w, https://biobuzz.io/wp-content/uploads/2021/02/Jeeva-Informatics-Hosts-Rare-Disease-Panel-on-Decentralized-Patient-Focused-Clinical-Trials-75x75.jpeg 75w" data-src="https://biobuzz.io/wp-content/uploads/2021/02/Jeeva-Informatics-Hosts-Rare-Disease-Panel-on-Decentralized-Patient-Focused-Clinical-Trials-300x300.jpeg" data-sizes="(max-width: 300px) 100vw, 300px" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img width="300" height="300" src="https://biobuzz.io/wp-content/uploads/2021/02/Jeeva-Informatics-Hosts-Rare-Disease-Panel-on-Decentralized-Patient-Focused-Clinical-Trials-300x300.jpeg" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload" alt="" srcset="https://biobuzz.io/wp-content/uploads/2021/02/Jeeva-Informatics-Hosts-Rare-Disease-Panel-on-Decentralized-Patient-Focused-Clinical-Trials-300x300.jpeg 300w, https://biobuzz.io/wp-content/uploads/2021/02/Jeeva-Informatics-Hosts-Rare-Disease-Panel-on-Decentralized-Patient-Focused-Clinical-Trials-150x150.jpeg 150w, https://biobuzz.io/wp-content/uploads/2021/02/Jeeva-Informatics-Hosts-Rare-Disease-Panel-on-Decentralized-Patient-Focused-Clinical-Trials-75x75.jpeg 75w" sizes="(max-width: 300px) 100vw, 300px" />

Published on : February 27, 2021February 28, 2021 Published by : Steven Surdez

In recognition of Rare Disease Day 2021, Jeeva Informatics (Jeeva) brought together a panel of experts to discuss the importance of transforming the clinical trial process for rare diseases. The panel included Annie Kennedy, Chief of Policy and Advocacy, EveryLife Foundation for Rare Diseases; Thomas Lester, Former Executive Director, Audentes Therapeutics; Scott Schliebner, Senior Vice President, Scientific Affairs & Therapeutic Expertise, PRA Health Sciences; and Dr. Eric Sid, Program Director, National Center for Advancing Translational Science, Office of Rare Disease Research, (NCATS)/NIH.

This Startup is on a Mission to Decentralize Cell and Gene Therapy Clinical Trials

<img width="300" height="300" alt="" data-srcset="https://biobuzz.io/wp-content/uploads/2020/02/CellGene-Jeeva-featured-img-300x300.png 300w, https://biobuzz.io/wp-content/uploads/2020/02/CellGene-Jeeva-featured-img-100x100.png 100w, https://biobuzz.io/wp-content/uploads/2020/02/CellGene-Jeeva-featured-img-150x150.png 150w" data-src="https://biobuzz.io/wp-content/uploads/2020/02/CellGene-Jeeva-featured-img-300x300.png" data-sizes="(max-width: 300px) 100vw, 300px" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img width="300" height="300" src="https://biobuzz.io/wp-content/uploads/2020/02/CellGene-Jeeva-featured-img-300x300.png" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload" alt="" srcset="https://biobuzz.io/wp-content/uploads/2020/02/CellGene-Jeeva-featured-img-300x300.png 300w, https://biobuzz.io/wp-content/uploads/2020/02/CellGene-Jeeva-featured-img-100x100.png 100w, https://biobuzz.io/wp-content/uploads/2020/02/CellGene-Jeeva-featured-img-150x150.png 150w" sizes="(max-width: 300px) 100vw, 300px" />

Published on : February 25, 2020February 25, 2020 Published by : Steven Surdez

This Startup is on a Mission to Decentralize Cell and Gene Therapy Clinical Trials For the cell and gene therapy revolution to be fully realized, physicians, research scientists, biomanufacturing experts, [….]

In Conversation: Dr. Harsha K. Rajasimha, IndoUSrare

<img width="300" height="300" alt="" data-srcset="https://biobuzz.io/wp-content/uploads/2020/02/InConv-Harsha-IndoUSrare-300x300.png 300w, https://biobuzz.io/wp-content/uploads/2020/02/InConv-Harsha-IndoUSrare-100x100.png 100w, https://biobuzz.io/wp-content/uploads/2020/02/InConv-Harsha-IndoUSrare-150x150.png 150w" data-src="https://biobuzz.io/wp-content/uploads/2020/02/InConv-Harsha-IndoUSrare-300x300.png" data-sizes="(max-width: 300px) 100vw, 300px" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img width="300" height="300" src="https://biobuzz.io/wp-content/uploads/2020/02/InConv-Harsha-IndoUSrare-300x300.png" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload" alt="" srcset="https://biobuzz.io/wp-content/uploads/2020/02/InConv-Harsha-IndoUSrare-300x300.png 300w, https://biobuzz.io/wp-content/uploads/2020/02/InConv-Harsha-IndoUSrare-100x100.png 100w, https://biobuzz.io/wp-content/uploads/2020/02/InConv-Harsha-IndoUSrare-150x150.png 150w" sizes="(max-width: 300px) 100vw, 300px" />

Published on : February 11, 2020March 4, 2021 Published by : Steven Surdez

In Conversation: Dr. Harsha K. Rajasimha, IndoUSrare BioBuzz recently sat down for a conversation with Dr. Harsha K. Rajasimha, a leading rare disease advocate, the founder of the non-profit, IndoUSrare, [….]